Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review

• Published in: Micromachines (Basel) Vol. 10; no. 10; p. 676
• Main Authors: Deng, Jiu, Wei, Wenbo, Chen, Zongzheng, Lin, Bingcheng, Zhao, Weijie, Luo, Yong, Zhang, Xiuli
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 07-10-2019; MDPI
• Subjects: Artificial organs; Bile; Biomedical engineering; Biomedical materials; Cytokines; drug hepatotoxicity; drug metabolism; Drugs; Endoplasmic reticulum; Enzymes; Extracellular matrix; Flow velocity; Liver; liver-on-a-chip; Metabolism; Microfluidics; Physiology; Review; Spheroids; Two dimensional models
• ISSN: 2072-666X; 2072-666X
• DOI: 10.3390/mi10100676

Hepatology and drug development for liver diseases require in vitro liver models. Typical models include 2D planar primary hepatocytes, hepatocyte spheroids, hepatocyte organoids, and liver-on-a-chip. Liver-on-a-chip has emerged as the mainstream model for drug development because it recapitulates the liver microenvironment and has good assay robustness such as reproducibility. Liver-on-a-chip with human primary cells can potentially correlate clinical testing. Liver-on-a-chip can not only predict drug hepatotoxicity and drug metabolism, but also connect other artificial organs on the chip for a human-on-a-chip, which can reflect the overall effect of a drug. Engineering an effective liver-on-a-chip device requires knowledge of multiple disciplines including chemistry, fluidic mechanics, cell biology, electrics, and optics. This review first introduces the physiological microenvironments in the liver, especially the cell composition and its specialized roles, and then summarizes the strategies to build a liver-on-a-chip via microfluidic technologies and its biomedical applications. In addition, the latest advancements of liver-on-a-chip technologies are discussed, which serve as a basis for further liver-on-a-chip research.